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Background
We intended to study the prevalence of HIV infection in
our patient population and to compare with the result
published before in a smaller population [1].
Materials and methods
We studied 13,023 patients tested for anti-HIV 1/2
between 1/5/2004 and 31/12/2005, belonging to Hospi-
tal Santo António (HGSA), to an Infection Disease Hospi-
tal (HJU), to an HIV Testing Center (HTC) and other
hospitals from North of Portugal (HNP). The test systems
for screening was HIV Vitros Eci-software version 3.0 (in
90% of cases) or Axsym® HIV Ag/Ab Combo Abbott or
Architect® HIV Ag/Ac Combo Abbott (10% of the cases).
The reactive samples were confirmed with the supplemen-
tal test Inno-Lia™ HIV I/II-Innogenetics.
Results
The results are shown in Table 1.
We find 705 individuals HIV-1 positive, 9 cases infected
with HIV-2 and 19 classified as HIV positive.
Conclusion
We found an overall seroprevalence of HIV infection of
5,6%. Last year our work had shown an HIV seropreva-
lence of 6,5% in a smaller population.*
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Table 1: 
Institution Number of Individuals 
Studied
Percentage of Population Individuals HIV positive HIV seroprevalence 
percentage
HGSA 9477 72,8 201 2,1
HJU 1267 9,7 451 35,6
HTC 2162 16,6 57 2,6
HNP 117 0,9 24 20,5